Addex Therapeutics Ltd
ADXN
$6.07
$0.132.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.62% | -- | -- | -19.33% | 22.38% |
| Total Depreciation and Amortization | 3.85% | -- | -- | -91.14% | -56.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.10% | -- | -- | 20.67% | -25.04% |
| Change in Net Operating Assets | 8.70% | -- | -- | -103.89% | 227.77% |
| Cash from Operations | -16.32% | -- | -- | -2,385.07% | 94.18% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.73% | -- | -- | -- | -241.51% |
| Cash from Investing | -105.73% | -- | -- | -- | -166.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.56% | -- | -- | 0.00% | 18.18% |
| Issuance of Common Stock | -76.79% | -- | -- | -94.64% | -- |
| Repurchase of Common Stock | -140.74% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.67% | -- | -- | 1,876.79% | -429.41% |
| Cash from Financing | -79.02% | -- | -- | 5,550.00% | -233.33% |
| Foreign Exchange rate Adjustments | 9.52% | -- | -- | -145.05% | 198.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -382.91% | -- | -- | -6,656.47% | 98.32% |